Chinese-Made Covid Tests Exempted From New UK Mandatory Health Standards huffingtonpost.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from huffingtonpost.co.uk Daily Mail and Mail on Sunday newspapers.
NICE’s five-year strategy sets a ‘positive vision for the future’
20th April 2021
The pharma industry has responded to the National Institute for Health and Care Excellence’s (NICE) new five-year strategy, announced yesterday.
In response to NICE’s new guideline recommendations, Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry (ABPI) commented: “Pharmaceutical companies are working on thousands of exciting new medicines and treatments, from rare disease gene therapies to mRNA vaccines for cancer.”
He added: “Today’s strategy sets out a positive vision for the future of NICE; one which will see it evolve with the science that makes these breakthroughs possible and build on its international reputation for producing evidence-based guidance.”
New NHS Medtech Funding Mandate welcomed by BIVDA
27th January 2021
The UK trade association for in vitro diagnostics (IVD) companies BIVDA has welcomed the NHS Medtech Funding Mandate, a new policy aimed at accelerating the uptake of medical devices, diagnostics and digital products in the NHS.
The new Mandate, which will come into effect from 1 April 2020, will aim to enable patients to access ‘pioneering’ IVD devices faster and with greater ease.
For products to qualify under the Mandate, they must demonstrate that they are effective, deliver material savings to the NHS, are cost-saving in-year and are affordable to the NHS.